In Vivo Fluorometric Assessment of Cyclosporine on Mitochondrial Function During Myocardial Ischemia and Reperfusion
Background Cyclosporine A (CsA) limits myocardial reperfusion injury and preserves mitochondrial integrity, but its influence on mitochondrial function has not been described in vivo. Auto-fluorescence of mitochondrial nicotinamide adenine dinucleotide and flavin adenine dinucleotide correlate with...
Gespeichert in:
Veröffentlicht in: | The Annals of thoracic surgery 2010-05, Vol.89 (5), p.1532-1537 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1537 |
---|---|
container_issue | 5 |
container_start_page | 1532 |
container_title | The Annals of thoracic surgery |
container_volume | 89 |
creator | Matsubara, Muneaki, MD Ranji, Mahsa, PhD Leshnower, Bradley G., MD Noma, Mio, MD Ratcliffe, Sarah J., PhD Chance, Britton, PhD Gorman, Robert C., MD Gorman, Joseph H., MD |
description | Background Cyclosporine A (CsA) limits myocardial reperfusion injury and preserves mitochondrial integrity, but its influence on mitochondrial function has not been described in vivo. Auto-fluorescence of mitochondrial nicotinamide adenine dinucleotide and flavin adenine dinucleotide correlate with mitochondrial dysfunction. We hypothesized that CsA limits mitochondrial dysfunction and that fluorometry can quantify this influence. Methods Seventeen rabbits were studied: untreated (UnT, n = 7), CsA preinfarction (CsAp, n = 6), and CsA on reperfusion (CsAr, n = 4). Animals underwent 30 minutes of myocardial ischemia and 3 hours reperfusion. Infarct size was determined by staining. Nicotinamide adenine dinucleotide and flavin adenine dinucleotide fluorescence was continually measured in the risk area. The redox ratio was calculated [flavin adenine dinucleotidef /(flavin adenine dinucleotidef + nicotinamide adenine dinucleotidef )]. Electron microscopy evaluated mitochondria morphology. Results The infarct size by group was 39.1% ± 1.7% in CsAp, 39.1% ± 1.7% in CsAr, and 53.4% ± 1.9% in UnT ( p < 0.001). During ischemia, the CsAp group demonstrated less hypoxic reduction, with the redox ratio decreasing to 75.6% ± 4.1% of baseline. The UnT and CsAr groups deceased to 67.1% ± 4.0% and 67.2% ± 3.6%, respectively ( p < 0.005). During reperfusion the UnT group redox ratio increased to 1.59 ± 0.04 times baseline. This increase was blunted in the CsAp (1.17 ± 0.04, p = 0.026) and CsAr (1.35 ± 0.02, p = 0.056) groups. Electron microscopy revealed reduced mitochondrial disruption in CsAp (19.7% ± 7.6%) and CsAr (18.1% ± 7.1%) rabbits compared with UnT (53.3% ± 12.5%). Conclusions Fluorometric spectroscopy can be used in vivo to quantitatively assess the time course of CsA's influence on the mitochondrial dysfunction associated with myocardial ischemia and reperfusion. |
doi_str_mv | 10.1016/j.athoracsur.2010.01.065 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3021279</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0003497510002250</els_id><sourcerecordid>733132477</sourcerecordid><originalsourceid>FETCH-LOGICAL-c563t-ab50b0424455ee8324dc18aa244c0a35f619138b27feaec8fec36c9aa2b19a0d3</originalsourceid><addsrcrecordid>eNqNkk2P0zAQhi0EYruFv4B8QZxS_BEnzWWlpdCl0q6Q-LpazmSydUnsYieV-u9x1LILnDhZnnn8znjeIYRytuCMF293CzNsfTAQx7AQLIUZX7BCPSEzrpTICqGqp2TGGJNZXpXqglzGuEtXkdLPyYVgOS_LUs7IsHH0uz14uu5GH3yPQ7BAr2PEGHt0A_UtXR2h83Hvg3VIvaN3dvCw9a4J1nR0PToYbAq_HxNwT--OHkxoptQmwhZ7a6hxDf2MewztGBP6gjxrTRfx5fmck2_rD19XH7PbTzeb1fVtBqqQQ2ZqxWqWizxXCnEpRd4AXxqTAsCMVG3BKy6XtShbNAjLFkEWUCWg5pVhjZyTq5Pufqx7bCD9J5hO74PtTThqb6z-O-PsVt_7g5ZpUKKsksCbs0DwP0eMg-5tBOw649CPUZdS8tRWmuScLE8kBB9jwPahCmd68kzv9KNnevJMM66TZ-npqz-7fHj426QEvD4DJoLp2mAc2PjIiTJXPM8T9-7EYZrpwWLQESw6wMYGhEE33v5PN1f_iEBnnU11f-AR486PwSXPNNdRaKa_TDs2rRiftksoJn8B-hLTCg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733132477</pqid></control><display><type>article</type><title>In Vivo Fluorometric Assessment of Cyclosporine on Mitochondrial Function During Myocardial Ischemia and Reperfusion</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Matsubara, Muneaki, MD ; Ranji, Mahsa, PhD ; Leshnower, Bradley G., MD ; Noma, Mio, MD ; Ratcliffe, Sarah J., PhD ; Chance, Britton, PhD ; Gorman, Robert C., MD ; Gorman, Joseph H., MD</creator><creatorcontrib>Matsubara, Muneaki, MD ; Ranji, Mahsa, PhD ; Leshnower, Bradley G., MD ; Noma, Mio, MD ; Ratcliffe, Sarah J., PhD ; Chance, Britton, PhD ; Gorman, Robert C., MD ; Gorman, Joseph H., MD</creatorcontrib><description>Background Cyclosporine A (CsA) limits myocardial reperfusion injury and preserves mitochondrial integrity, but its influence on mitochondrial function has not been described in vivo. Auto-fluorescence of mitochondrial nicotinamide adenine dinucleotide and flavin adenine dinucleotide correlate with mitochondrial dysfunction. We hypothesized that CsA limits mitochondrial dysfunction and that fluorometry can quantify this influence. Methods Seventeen rabbits were studied: untreated (UnT, n = 7), CsA preinfarction (CsAp, n = 6), and CsA on reperfusion (CsAr, n = 4). Animals underwent 30 minutes of myocardial ischemia and 3 hours reperfusion. Infarct size was determined by staining. Nicotinamide adenine dinucleotide and flavin adenine dinucleotide fluorescence was continually measured in the risk area. The redox ratio was calculated [flavin adenine dinucleotidef /(flavin adenine dinucleotidef + nicotinamide adenine dinucleotidef )]. Electron microscopy evaluated mitochondria morphology. Results The infarct size by group was 39.1% ± 1.7% in CsAp, 39.1% ± 1.7% in CsAr, and 53.4% ± 1.9% in UnT ( p < 0.001). During ischemia, the CsAp group demonstrated less hypoxic reduction, with the redox ratio decreasing to 75.6% ± 4.1% of baseline. The UnT and CsAr groups deceased to 67.1% ± 4.0% and 67.2% ± 3.6%, respectively ( p < 0.005). During reperfusion the UnT group redox ratio increased to 1.59 ± 0.04 times baseline. This increase was blunted in the CsAp (1.17 ± 0.04, p = 0.026) and CsAr (1.35 ± 0.02, p = 0.056) groups. Electron microscopy revealed reduced mitochondrial disruption in CsAp (19.7% ± 7.6%) and CsAr (18.1% ± 7.1%) rabbits compared with UnT (53.3% ± 12.5%). Conclusions Fluorometric spectroscopy can be used in vivo to quantitatively assess the time course of CsA's influence on the mitochondrial dysfunction associated with myocardial ischemia and reperfusion.</description><identifier>ISSN: 0003-4975</identifier><identifier>EISSN: 1552-6259</identifier><identifier>DOI: 10.1016/j.athoracsur.2010.01.065</identifier><identifier>PMID: 20417773</identifier><identifier>CODEN: ATHSAK</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Animals ; Biological and medical sciences ; Cardiology. Vascular system ; Cardiothoracic Surgery ; Coronary heart disease ; Cyclosporine - pharmacology ; Disease Models, Animal ; Heart ; Immunohistochemistry ; Ischemic Preconditioning, Myocardial ; Medical sciences ; Mitochondria, Heart - drug effects ; Mitochondria, Heart - physiology ; Myocardial Infarction - pathology ; Myocardial Infarction - prevention & control ; Myocardial Ischemia - pathology ; Myocardial Ischemia - therapy ; Myocardial Reperfusion - methods ; Myocardial Reperfusion Injury - pathology ; Myocardial Reperfusion Injury - prevention & control ; Myocarditis. Cardiomyopathies ; Pneumology ; Rabbits ; Random Allocation ; Reference Values ; Risk Assessment ; Spectrometry, Fluorescence ; Surgery</subject><ispartof>The Annals of thoracic surgery, 2010-05, Vol.89 (5), p.1532-1537</ispartof><rights>The Society of Thoracic Surgeons</rights><rights>2010 The Society of Thoracic Surgeons</rights><rights>2015 INIST-CNRS</rights><rights>Copyright (c) 2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.</rights><rights>2010 by The Society of Thoracic Surgeons 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c563t-ab50b0424455ee8324dc18aa244c0a35f619138b27feaec8fec36c9aa2b19a0d3</citedby><cites>FETCH-LOGICAL-c563t-ab50b0424455ee8324dc18aa244c0a35f619138b27feaec8fec36c9aa2b19a0d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22745144$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20417773$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Matsubara, Muneaki, MD</creatorcontrib><creatorcontrib>Ranji, Mahsa, PhD</creatorcontrib><creatorcontrib>Leshnower, Bradley G., MD</creatorcontrib><creatorcontrib>Noma, Mio, MD</creatorcontrib><creatorcontrib>Ratcliffe, Sarah J., PhD</creatorcontrib><creatorcontrib>Chance, Britton, PhD</creatorcontrib><creatorcontrib>Gorman, Robert C., MD</creatorcontrib><creatorcontrib>Gorman, Joseph H., MD</creatorcontrib><title>In Vivo Fluorometric Assessment of Cyclosporine on Mitochondrial Function During Myocardial Ischemia and Reperfusion</title><title>The Annals of thoracic surgery</title><addtitle>Ann Thorac Surg</addtitle><description>Background Cyclosporine A (CsA) limits myocardial reperfusion injury and preserves mitochondrial integrity, but its influence on mitochondrial function has not been described in vivo. Auto-fluorescence of mitochondrial nicotinamide adenine dinucleotide and flavin adenine dinucleotide correlate with mitochondrial dysfunction. We hypothesized that CsA limits mitochondrial dysfunction and that fluorometry can quantify this influence. Methods Seventeen rabbits were studied: untreated (UnT, n = 7), CsA preinfarction (CsAp, n = 6), and CsA on reperfusion (CsAr, n = 4). Animals underwent 30 minutes of myocardial ischemia and 3 hours reperfusion. Infarct size was determined by staining. Nicotinamide adenine dinucleotide and flavin adenine dinucleotide fluorescence was continually measured in the risk area. The redox ratio was calculated [flavin adenine dinucleotidef /(flavin adenine dinucleotidef + nicotinamide adenine dinucleotidef )]. Electron microscopy evaluated mitochondria morphology. Results The infarct size by group was 39.1% ± 1.7% in CsAp, 39.1% ± 1.7% in CsAr, and 53.4% ± 1.9% in UnT ( p < 0.001). During ischemia, the CsAp group demonstrated less hypoxic reduction, with the redox ratio decreasing to 75.6% ± 4.1% of baseline. The UnT and CsAr groups deceased to 67.1% ± 4.0% and 67.2% ± 3.6%, respectively ( p < 0.005). During reperfusion the UnT group redox ratio increased to 1.59 ± 0.04 times baseline. This increase was blunted in the CsAp (1.17 ± 0.04, p = 0.026) and CsAr (1.35 ± 0.02, p = 0.056) groups. Electron microscopy revealed reduced mitochondrial disruption in CsAp (19.7% ± 7.6%) and CsAr (18.1% ± 7.1%) rabbits compared with UnT (53.3% ± 12.5%). Conclusions Fluorometric spectroscopy can be used in vivo to quantitatively assess the time course of CsA's influence on the mitochondrial dysfunction associated with myocardial ischemia and reperfusion.</description><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Cardiology. Vascular system</subject><subject>Cardiothoracic Surgery</subject><subject>Coronary heart disease</subject><subject>Cyclosporine - pharmacology</subject><subject>Disease Models, Animal</subject><subject>Heart</subject><subject>Immunohistochemistry</subject><subject>Ischemic Preconditioning, Myocardial</subject><subject>Medical sciences</subject><subject>Mitochondria, Heart - drug effects</subject><subject>Mitochondria, Heart - physiology</subject><subject>Myocardial Infarction - pathology</subject><subject>Myocardial Infarction - prevention & control</subject><subject>Myocardial Ischemia - pathology</subject><subject>Myocardial Ischemia - therapy</subject><subject>Myocardial Reperfusion - methods</subject><subject>Myocardial Reperfusion Injury - pathology</subject><subject>Myocardial Reperfusion Injury - prevention & control</subject><subject>Myocarditis. Cardiomyopathies</subject><subject>Pneumology</subject><subject>Rabbits</subject><subject>Random Allocation</subject><subject>Reference Values</subject><subject>Risk Assessment</subject><subject>Spectrometry, Fluorescence</subject><subject>Surgery</subject><issn>0003-4975</issn><issn>1552-6259</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkk2P0zAQhi0EYruFv4B8QZxS_BEnzWWlpdCl0q6Q-LpazmSydUnsYieV-u9x1LILnDhZnnn8znjeIYRytuCMF293CzNsfTAQx7AQLIUZX7BCPSEzrpTICqGqp2TGGJNZXpXqglzGuEtXkdLPyYVgOS_LUs7IsHH0uz14uu5GH3yPQ7BAr2PEGHt0A_UtXR2h83Hvg3VIvaN3dvCw9a4J1nR0PToYbAq_HxNwT--OHkxoptQmwhZ7a6hxDf2MewztGBP6gjxrTRfx5fmck2_rD19XH7PbTzeb1fVtBqqQQ2ZqxWqWizxXCnEpRd4AXxqTAsCMVG3BKy6XtShbNAjLFkEWUCWg5pVhjZyTq5Pufqx7bCD9J5hO74PtTThqb6z-O-PsVt_7g5ZpUKKsksCbs0DwP0eMg-5tBOw649CPUZdS8tRWmuScLE8kBB9jwPahCmd68kzv9KNnevJMM66TZ-npqz-7fHj426QEvD4DJoLp2mAc2PjIiTJXPM8T9-7EYZrpwWLQESw6wMYGhEE33v5PN1f_iEBnnU11f-AR486PwSXPNNdRaKa_TDs2rRiftksoJn8B-hLTCg</recordid><startdate>20100501</startdate><enddate>20100501</enddate><creator>Matsubara, Muneaki, MD</creator><creator>Ranji, Mahsa, PhD</creator><creator>Leshnower, Bradley G., MD</creator><creator>Noma, Mio, MD</creator><creator>Ratcliffe, Sarah J., PhD</creator><creator>Chance, Britton, PhD</creator><creator>Gorman, Robert C., MD</creator><creator>Gorman, Joseph H., MD</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20100501</creationdate><title>In Vivo Fluorometric Assessment of Cyclosporine on Mitochondrial Function During Myocardial Ischemia and Reperfusion</title><author>Matsubara, Muneaki, MD ; Ranji, Mahsa, PhD ; Leshnower, Bradley G., MD ; Noma, Mio, MD ; Ratcliffe, Sarah J., PhD ; Chance, Britton, PhD ; Gorman, Robert C., MD ; Gorman, Joseph H., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c563t-ab50b0424455ee8324dc18aa244c0a35f619138b27feaec8fec36c9aa2b19a0d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Cardiology. Vascular system</topic><topic>Cardiothoracic Surgery</topic><topic>Coronary heart disease</topic><topic>Cyclosporine - pharmacology</topic><topic>Disease Models, Animal</topic><topic>Heart</topic><topic>Immunohistochemistry</topic><topic>Ischemic Preconditioning, Myocardial</topic><topic>Medical sciences</topic><topic>Mitochondria, Heart - drug effects</topic><topic>Mitochondria, Heart - physiology</topic><topic>Myocardial Infarction - pathology</topic><topic>Myocardial Infarction - prevention & control</topic><topic>Myocardial Ischemia - pathology</topic><topic>Myocardial Ischemia - therapy</topic><topic>Myocardial Reperfusion - methods</topic><topic>Myocardial Reperfusion Injury - pathology</topic><topic>Myocardial Reperfusion Injury - prevention & control</topic><topic>Myocarditis. Cardiomyopathies</topic><topic>Pneumology</topic><topic>Rabbits</topic><topic>Random Allocation</topic><topic>Reference Values</topic><topic>Risk Assessment</topic><topic>Spectrometry, Fluorescence</topic><topic>Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Matsubara, Muneaki, MD</creatorcontrib><creatorcontrib>Ranji, Mahsa, PhD</creatorcontrib><creatorcontrib>Leshnower, Bradley G., MD</creatorcontrib><creatorcontrib>Noma, Mio, MD</creatorcontrib><creatorcontrib>Ratcliffe, Sarah J., PhD</creatorcontrib><creatorcontrib>Chance, Britton, PhD</creatorcontrib><creatorcontrib>Gorman, Robert C., MD</creatorcontrib><creatorcontrib>Gorman, Joseph H., MD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Annals of thoracic surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Matsubara, Muneaki, MD</au><au>Ranji, Mahsa, PhD</au><au>Leshnower, Bradley G., MD</au><au>Noma, Mio, MD</au><au>Ratcliffe, Sarah J., PhD</au><au>Chance, Britton, PhD</au><au>Gorman, Robert C., MD</au><au>Gorman, Joseph H., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In Vivo Fluorometric Assessment of Cyclosporine on Mitochondrial Function During Myocardial Ischemia and Reperfusion</atitle><jtitle>The Annals of thoracic surgery</jtitle><addtitle>Ann Thorac Surg</addtitle><date>2010-05-01</date><risdate>2010</risdate><volume>89</volume><issue>5</issue><spage>1532</spage><epage>1537</epage><pages>1532-1537</pages><issn>0003-4975</issn><eissn>1552-6259</eissn><coden>ATHSAK</coden><abstract>Background Cyclosporine A (CsA) limits myocardial reperfusion injury and preserves mitochondrial integrity, but its influence on mitochondrial function has not been described in vivo. Auto-fluorescence of mitochondrial nicotinamide adenine dinucleotide and flavin adenine dinucleotide correlate with mitochondrial dysfunction. We hypothesized that CsA limits mitochondrial dysfunction and that fluorometry can quantify this influence. Methods Seventeen rabbits were studied: untreated (UnT, n = 7), CsA preinfarction (CsAp, n = 6), and CsA on reperfusion (CsAr, n = 4). Animals underwent 30 minutes of myocardial ischemia and 3 hours reperfusion. Infarct size was determined by staining. Nicotinamide adenine dinucleotide and flavin adenine dinucleotide fluorescence was continually measured in the risk area. The redox ratio was calculated [flavin adenine dinucleotidef /(flavin adenine dinucleotidef + nicotinamide adenine dinucleotidef )]. Electron microscopy evaluated mitochondria morphology. Results The infarct size by group was 39.1% ± 1.7% in CsAp, 39.1% ± 1.7% in CsAr, and 53.4% ± 1.9% in UnT ( p < 0.001). During ischemia, the CsAp group demonstrated less hypoxic reduction, with the redox ratio decreasing to 75.6% ± 4.1% of baseline. The UnT and CsAr groups deceased to 67.1% ± 4.0% and 67.2% ± 3.6%, respectively ( p < 0.005). During reperfusion the UnT group redox ratio increased to 1.59 ± 0.04 times baseline. This increase was blunted in the CsAp (1.17 ± 0.04, p = 0.026) and CsAr (1.35 ± 0.02, p = 0.056) groups. Electron microscopy revealed reduced mitochondrial disruption in CsAp (19.7% ± 7.6%) and CsAr (18.1% ± 7.1%) rabbits compared with UnT (53.3% ± 12.5%). Conclusions Fluorometric spectroscopy can be used in vivo to quantitatively assess the time course of CsA's influence on the mitochondrial dysfunction associated with myocardial ischemia and reperfusion.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>20417773</pmid><doi>10.1016/j.athoracsur.2010.01.065</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0003-4975 |
ispartof | The Annals of thoracic surgery, 2010-05, Vol.89 (5), p.1532-1537 |
issn | 0003-4975 1552-6259 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3021279 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Animals Biological and medical sciences Cardiology. Vascular system Cardiothoracic Surgery Coronary heart disease Cyclosporine - pharmacology Disease Models, Animal Heart Immunohistochemistry Ischemic Preconditioning, Myocardial Medical sciences Mitochondria, Heart - drug effects Mitochondria, Heart - physiology Myocardial Infarction - pathology Myocardial Infarction - prevention & control Myocardial Ischemia - pathology Myocardial Ischemia - therapy Myocardial Reperfusion - methods Myocardial Reperfusion Injury - pathology Myocardial Reperfusion Injury - prevention & control Myocarditis. Cardiomyopathies Pneumology Rabbits Random Allocation Reference Values Risk Assessment Spectrometry, Fluorescence Surgery |
title | In Vivo Fluorometric Assessment of Cyclosporine on Mitochondrial Function During Myocardial Ischemia and Reperfusion |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T12%3A44%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20Vivo%20Fluorometric%20Assessment%20of%20Cyclosporine%20on%20Mitochondrial%20Function%20During%20Myocardial%20Ischemia%20and%20Reperfusion&rft.jtitle=The%20Annals%20of%20thoracic%20surgery&rft.au=Matsubara,%20Muneaki,%20MD&rft.date=2010-05-01&rft.volume=89&rft.issue=5&rft.spage=1532&rft.epage=1537&rft.pages=1532-1537&rft.issn=0003-4975&rft.eissn=1552-6259&rft.coden=ATHSAK&rft_id=info:doi/10.1016/j.athoracsur.2010.01.065&rft_dat=%3Cproquest_pubme%3E733132477%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733132477&rft_id=info:pmid/20417773&rft_els_id=1_s2_0_S0003497510002250&rfr_iscdi=true |